Special Issue "Personalized Medicine for Neurodegenerative Dementia"
Deadline for manuscript submissions: closed (5 July 2023) | Viewed by 22279
2. Division of Neuropsychiatry, Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX 77030, USA
Interests: dementia; neuropsychiatry; neuropsychology; neuroimaging; schizophrenia; mood disorders; genetics; neuroinflammation; movement disorders; neurodegeneration; childhood trauma
Dear Colleagues,Neuropsychiatric symptoms/disorders in neurodegenerative dementias (i.e., Alzheimer's Disease, Lewy Body Disease, Fronto-temporal Dementia, Parkinson's Disease and Atypical parkinsonisms) are a group of heterogeneous clinical manifestations. Epidemiology and phenomenology are highly variable depending, among the others, on the specific diagnosis, type of assessment, phases of the illness and associated biomarkers and polytherapy. The extreme variability of treatment response and side effects make the management of the neuropsychiatric phenomena associated with neurodegenerative dementias difficult and make of greatest importance the personalized medicine approach
Prof. Dr. Gianfranco Spalletta
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- mild cognitive impairment
- subjective cognitive complaint
- risk factors
- early diagnosis
- Alzheimer’s disease
- frontotemporal dementia
- Lewy body disease
- Parkinson’s disease dementia
- progressive supranuclear palsy
- cortico-basal degeneration
- mood disorder
- aberrant motor behavior